Browse 6,000+ US-traded stocks with real-time quotes, AI-powered analysis, options flow intelligence, earnings predictions, and multi-signal convergence detection. Filter by sector, market cap, price range, and signal strength to find stocks matching your investment criteria.
What You Get
Real-time stock quotes from a 5-source consensus pricing engine
AI analysis with buy/sell/hold signals backed by 12 independent indicators
Options flow tracking — unusual activity, put/call ratios, and open interest anomalies
Earnings predictions with historical beat rates and EPS estimates
Convergence scanner detecting when multiple signals align on a single stock
Sector and industry filtering across all 11 GICS sectors
Frequently Asked Questions
Is the stock screener free?
Yes, iGotFomo provides completely free access to real-time stock data, AI analysis, and all screening tools with no account required.
How many stocks are covered?
Over 6,000 US-traded stocks including all NYSE, NASDAQ, and AMEX listings. Data is updated in real-time during market hours.
APUS Stock Price Today $1.30 (-2.26%) ▼
About Apimeds Pharmaceuticals US, Inc (APUS)
Apimeds Pharmaceuticals US, Inc (APUS) is a publicly traded company in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View real-time stock data, AI analysis, options flow, and convergence signals for APUS on iGotFomo.
Apimeds Pharmaceuticals US, Inc (APUS) is a publicly traded company in the Healthcare sector, operating in the Drug Manufacturers - Specialty & Generic industry.
What is the current APUS stock price?
As of the latest trading session, APUS trades at $1.30 per share, with a daily change of -2.26%.
What is APUS's market capitalization?
Apimeds Pharmaceuticals US, Inc has a market capitalization of $16 million, making it a micro-cap stock.
What sector does APUS belong to?
Apimeds Pharmaceuticals US, Inc operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View all Healthcare stocks.